Medicines related to Valproate: Risk of abnormal pregnancy outcomes
Topics:
Date published:
This letter is to inform you of important new information and strengthened warnings related to safety of medicines related to valproate (sodium valproate, valproic acid [brand leader: Epilim] and valproate semisodium [brand leader: Depakote]), following completion of a Europe-wide review.